What is the level of liabilities of Aarti Drugs this year?
Aarti Drugs has a debt balance of 0 INR this year.
Aarti Drugs Liabilities 2024
Aarti Drugs Liabilities
0 INR
Ticker
AARTIDRUGS.NS
ISIN
INE767A01016
In 2024, Aarti Drugs's total liabilities amounted to 0 INR, a -100% difference from the 11.72 B INR total liabilities in the previous year.
Aarti Drugs Aktienanalyse
What does Aarti Drugs do?
Aarti Drugs ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Aarti Drugs's Liabilities
Aarti Drugs's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Aarti Drugs's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Aarti Drugs's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Aarti Drugs's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Aarti Drugs’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Aarti Drugs stock
What were the liabilities of Aarti Drugs compared to the previous year?
The liabilities of Aarti Drugs have increased by -100% dropped compared to the previous year.
What are the consequences of high debt for investors of Aarti Drugs?
High liabilities can pose a risk for investors of Aarti Drugs, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Aarti Drugs?
Low liabilities mean that Aarti Drugs has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Aarti Drugs affect the company?
An increase in liabilities of Aarti Drugs can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Aarti Drugs affect the company?
A decrease in the liabilities of Aarti Drugs can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Aarti Drugs?
Some factors that can influence the liabilities of Aarti Drugs include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Aarti Drugs so important for investors?
The liabilities of Aarti Drugs are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Aarti Drugs take to modify the liabilities?
To change its liabilities, Aarti Drugs can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Aarti Drugs pay?
Over the past 12 months, Aarti Drugs paid a dividend of 1 INR . This corresponds to a dividend yield of about 0.19 %. For the coming 12 months, Aarti Drugs is expected to pay a dividend of 1.18 INR.
What is the dividend yield of Aarti Drugs?
The current dividend yield of Aarti Drugs is 0.19 %.
When does Aarti Drugs pay dividends?
Aarti Drugs pays a quarterly dividend. This is distributed in the months of December, March, March, March.
How secure is the dividend of Aarti Drugs?
Aarti Drugs paid dividends every year for the past 5 years.
What is the dividend of Aarti Drugs?
For the upcoming 12 months, dividends amounting to 1.18 INR are expected. This corresponds to a dividend yield of 0.23 %.
In which sector is Aarti Drugs located?
Aarti Drugs is assigned to the 'Health' sector.
Wann musste ich die Aktien von Aarti Drugs kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Aarti Drugs from 2/23/2024 amounting to 1 INR, you needed to have the stock in your portfolio before the ex-date on 2/6/2024.
When did Aarti Drugs pay the last dividend?
The last dividend was paid out on 2/23/2024.
What was the dividend of Aarti Drugs in the year 2023?
In the year 2023, Aarti Drugs distributed 1 INR as dividends.
In which currency does Aarti Drugs pay out the dividend?
The dividends of Aarti Drugs are distributed in INR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Aarti Drugs
Our stock analysis for Aarti Drugs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aarti Drugs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.